Volume 13, Number 8—August 2007
Dispatch
Invasive Meningococcal Disease, Utah, 1995–2005
Rachelle B. Boulton*†
, Stephen C. Alder*, Susan Mottice†, A. Peter Catinella*, and Carrie L. Byington†
, Stephen C. Alder*, Susan Mottice†, A. Peter Catinella*, and Carrie L. Byington†
Table 2
Serogroup distribution of invasive meningococcal disease by period*
| Neisseria meningitidis serogroup | Period 1 |
Period 2 |
|||||
|---|---|---|---|---|---|---|---|
| Utah | United States | p value | Utah | United States | p value | ||
| B | 32.1% | 29.2% | 0.5701 | 11.3% | 39.7% | 0.0002 | |
| Y | 26.1% | 32.0% | 0.2773 | 50.0% | 23.9% | <0.0001 | |
| C | 25.0% | 25.5% | 0.9298 | 15.9% | 21.4% | 0.3783 | |
| Other | 16.7% | 13.4% | 0.4084 | 22.7% | 15.0% | 0.1633 | |
*Period 1, 1995–1999; period 2, 2000–2005. US data estimates based on information collected from Active Bacterial Core surveillance sites.
Page created: June 30, 2010
Page updated: June 30, 2010
Page reviewed: June 30, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.